Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hollenbaugh

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Transplantation|January 15, 1996
CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathwayC P Larsen, D Z Alexander, D Hollenbaugh, et al.
Cell|January 29, 1993
The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndromeA Aruffo, M Farrington, D Hollenbaugh, et al.
International Immunology|August 1, 1997
Thymus dysfunction and chronic inflammatory disease in gp39 transgenic miceC H Clegg, J T Rulffes, H S Haugen, et al.
Biochemistry|August 8, 1995
Analysis of gp39/CD40 interactions using molecular models and site-directed mutagenesisJ Bajorath, J S Marken, N J Chalupny, et al.
European Journal of Immunology|October 1, 1996
CD40 is functionally expressed on human keratinocytesR W Denfeld, D Hollenbaugh, A Fehrenbach, et al.
The EMBO Journal|December 1, 1992
The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activityD Hollenbaugh, L S Grosmaire, C D Kullas, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1994
CD40 ligand expression is defective in a subset of patients with common variable immunodeficiencyM Farrington, L S Grosmaire, S Nonoyama, et al.
The Journal of Clinical Investigation|August 1, 1994
The random inactivation of the X chromosome carrying the defective gene responsible for X-linked hyper IgM syndrome (X-HIM) in female carriers of HIGM1D Hollenbaugh, L H Wu, H D Ochs, et al.
Biochemistry|February 14, 1995
Identification of residues on CD40 and its ligand which are critical for the receptor-ligand interactionJ Bajorath, N J Chalupny, J S Marken, et al.
Nature|May 30, 1996
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathwaysC P Larsen, E T Elwood, D Z Alexander, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Transplantation|January 15, 1996
CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathwayC P Larsen, D Z Alexander, D Hollenbaugh, et al.
Cell|January 29, 1993
The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndromeA Aruffo, M Farrington, D Hollenbaugh, et al.
International Immunology|August 1, 1997
Thymus dysfunction and chronic inflammatory disease in gp39 transgenic miceC H Clegg, J T Rulffes, H S Haugen, et al.
Biochemistry|August 8, 1995
Analysis of gp39/CD40 interactions using molecular models and site-directed mutagenesisJ Bajorath, J S Marken, N J Chalupny, et al.
European Journal of Immunology|October 1, 1996
CD40 is functionally expressed on human keratinocytesR W Denfeld, D Hollenbaugh, A Fehrenbach, et al.
The EMBO Journal|December 1, 1992
The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activityD Hollenbaugh, L S Grosmaire, C D Kullas, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1994
CD40 ligand expression is defective in a subset of patients with common variable immunodeficiencyM Farrington, L S Grosmaire, S Nonoyama, et al.
The Journal of Clinical Investigation|August 1, 1994
The random inactivation of the X chromosome carrying the defective gene responsible for X-linked hyper IgM syndrome (X-HIM) in female carriers of HIGM1D Hollenbaugh, L H Wu, H D Ochs, et al.
Biochemistry|February 14, 1995
Identification of residues on CD40 and its ligand which are critical for the receptor-ligand interactionJ Bajorath, N J Chalupny, J S Marken, et al.
Nature|May 30, 1996
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathwaysC P Larsen, E T Elwood, D Z Alexander, et al.
Pageof 5